NASDAQ:KOOL - Cesca Therapeutics News Headlines

$2.98
-0.08 (-2.61 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
$2.92
Now: $2.98
$3.11
50-Day Range
$2.72
MA: $3.11
$3.69
52-Week Range
$2.10
Now: $2.98
$5.25
Volume19,306 shs
Average Volume25,948 shs
Market Capitalization$7.21 million
P/E RatioN/A
Dividend YieldN/A
Beta1

Headlines

Cesca Therapeutics (NASDAQ KOOL) News Headlines

Source:
DateHeadline
HC Wainwright Reiterates Buy Rating for Cesca Therapeutics (NASDAQ:KOOL)HC Wainwright Reiterates Buy Rating for Cesca Therapeutics (NASDAQ:KOOL)
www.americanbankingnews.com - August 14 at 12:59 PM
Cesca Therapeutics (NASDAQ:KOOL) Issues  Earnings ResultsCesca Therapeutics (NASDAQ:KOOL) Issues Earnings Results
www.americanbankingnews.com - August 14 at 11:49 AM
Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q2 2019 Results - Earnings Call TranscriptCesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 14 at 12:20 AM
Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate UpdateCesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 13 at 7:19 PM
Brokerages Expect Cesca Therapeutics Inc (NASDAQ:KOOL) to Announce ($0.60) EPSBrokerages Expect Cesca Therapeutics Inc (NASDAQ:KOOL) to Announce ($0.60) EPS
www.americanbankingnews.com - August 10 at 10:18 AM
Cesca Therapeutics (KOOL) Set to Announce Quarterly Earnings on TuesdayCesca Therapeutics (KOOL) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 7 at 10:02 AM
Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On August 13Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On August 13
finance.yahoo.com - August 6 at 8:33 AM
Americas Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis AXP® II SystemAmerica's Largest Cord Blood Bank, CBR®, Upgrading to ThermoGenesis' AXP® II System
www.prnewswire.com - July 23 at 8:40 AM
Some Cesca Therapeutics (NASDAQ:KOOL) Shareholders Have Copped A 99% Share Price Wipe OutSome Cesca Therapeutics (NASDAQ:KOOL) Shareholders Have Copped A 99% Share Price Wipe Out
finance.yahoo.com - July 5 at 5:28 PM
AXP II deal in India fails to lift Cesca, shares down 7% premarketAXP II deal in India fails to lift Cesca, shares down 7% premarket
seekingalpha.com - June 25 at 10:32 AM
ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood ProcessingThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing
finance.yahoo.com - June 18 at 5:25 PM
ThermoGenesis Cord Blood Processing System Wins Health Canada ApprovalThermoGenesis Cord Blood Processing System Wins Health Canada Approval
finance.yahoo.com - June 18 at 5:25 PM
ThermoGenesis to Participate in The Orthobiologic Institutes 10th Annual PRP & Regenerative Medicine SymposiumThermoGenesis to Participate in The Orthobiologic Institute's 10th Annual PRP & Regenerative Medicine Symposium
finance.yahoo.com - June 5 at 9:10 AM
Does Market Volatility Impact Cesca Therapeutics Inc.s (NASDAQ:KOOL) Share Price?Does Market Volatility Impact Cesca Therapeutics Inc.'s (NASDAQ:KOOL) Share Price?
finance.yahoo.com - May 16 at 10:49 AM
Does Market Volatility Impact Cesca Therapeutics Inc.'s (NASDAQ:KOOL) Share Price?Does Market Volatility Impact Cesca Therapeutics Inc.'s (NASDAQ:KOOL) Share Price?
finance.yahoo.com - May 16 at 10:49 AM
Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q1 2019 Results - Earnings Call TranscriptCesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 9:24 AM
Cesca Therapeutics EPS in-line, misses on revenueCesca Therapeutics EPS in-line, misses on revenue
seekingalpha.com - May 14 at 7:14 PM
Cesca Therapeutics Announces First Quarter 2019 Financial Results And Provides Corporate UpdateCesca Therapeutics Announces First Quarter 2019 Financial Results And Provides Corporate Update
finance.yahoo.com - May 14 at 7:14 PM
Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2019 and Host a Conference Call on May 14Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2019 and Host a Conference Call on May 14
finance.yahoo.com - May 7 at 9:17 AM
Will Cesca Therapeutics (KOOL) Report Negative Q1 Earnings? What You Should KnowWill Cesca Therapeutics (KOOL) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - May 6 at 6:46 PM
ThermoGenesis Releases its Enhanced X-MINI® CD3 Selection Kit for the Research MarketThermoGenesis Releases its Enhanced X-MINI® CD3 Selection Kit for the Research Market
finance.yahoo.com - April 17 at 9:34 AM
ThermoGenesis AXP® II and PXP® Systems Now Registered and Available in ThailandThermoGenesis AXP® II and PXP® Systems Now Registered and Available in Thailand
finance.yahoo.com - April 10 at 10:56 AM
Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q4 2018 Results - Earnings Call TranscriptCesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 26 at 9:32 AM
Cesca Therapeutics Announces Fiscal 2018 Year End Financial Results And Provides Corporate UpdateCesca Therapeutics Announces Fiscal 2018 Year End Financial Results And Provides Corporate Update
finance.yahoo.com - March 25 at 6:35 PM
Cesca Therapeutics To Announce Financial Results For The Fourth Quarter Ended December 31, 2018 and Host Conference Call On March 25Cesca Therapeutics To Announce Financial Results For The Fourth Quarter Ended December 31, 2018 and Host Conference Call On March 25
finance.yahoo.com - March 20 at 9:08 AM
ThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells - PRNewswireThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells - PRNewswire
www.prnewswire.com - February 25 at 6:16 PM
ThermoGenesis PXP System OKd in Canada - Seeking AlphaThermoGenesis' PXP System OK'd in Canada - Seeking Alpha
seekingalpha.com - February 25 at 6:16 PM
ThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow CellsThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells
finance.yahoo.com - February 25 at 10:09 AM
ThermoGenesis Corp X-Series Control Module and Docking Stations Cleared for Labelling by TÜV Rheinland with the cTUVus Electrical Safety Mark - PRNewswireThermoGenesis Corp X-Series Control Module and Docking Stations Cleared for Labelling by TÜV Rheinland with the cTUVus Electrical Safety Mark - PRNewswire
www.prnewswire.com - February 13 at 5:48 PM
ThermoGenesis Corp X-Series Control Module and Docking Stations Cleared for Labelling by TÜV Rheinland with the cTUVus Electrical Safety MarkThermoGenesis Corp X-Series Control Module and Docking Stations Cleared for Labelling by TÜV Rheinland with the cTUVus Electrical Safety Mark
finance.yahoo.com - February 11 at 10:42 AM
Cesca Therapeutics to Present at the BIO CEO & Investor Conference - PRNewswireCesca Therapeutics to Present at the BIO CEO & Investor Conference - PRNewswire
www.prnewswire.com - February 6 at 9:35 AM
Cesca Therapeutics to Present at the BIO CEO & Investor ConferenceCesca Therapeutics to Present at the BIO CEO & Investor Conference
finance.yahoo.com - February 6 at 9:35 AM
Cesca Therapeutics to Present at the BIO CEO & Investor ConferenceCesca Therapeutics to Present at the BIO CEO & Investor Conference
www.prnewswire.com - February 6 at 8:37 AM
ThermoGenesis Corp Signs Strategic Supply Agreement with Orthohealing Center Management to Provide its PXP® Point-of-Care System to Orthohealing Method™ Physician MembersThermoGenesis Corp Signs Strategic Supply Agreement with Orthohealing Center Management to Provide it's PXP® Point-of-Care System to Orthohealing Method™ Physician Members
finance.yahoo.com - February 1 at 9:31 AM
ThermoGenesis Corp® Completes Construction and Qualification of In-House Clean Room for Assembly of All X-Series™ Cell Processing DisposablesThermoGenesis Corp® Completes Construction and Qualification of In-House Clean Room for Assembly of All X-Series™ Cell Processing Disposables
finance.yahoo.com - January 21 at 10:14 AM
Cesca Therapeutics Acquires Remaining Ownership Stake in ThermoGenesis and Forms New ThermoGenesis Subsidiary, CARTXpress Bio, Inc., to Focus on its CAR-TXpress Cellular Processing Platform - PRNewswireCesca Therapeutics Acquires Remaining Ownership Stake in ThermoGenesis and Forms New ThermoGenesis Subsidiary, CARTXpress Bio, Inc., to Focus on its CAR-TXpress Cellular Processing Platform - PRNewswire
www.prnewswire.com - January 5 at 4:46 PM
Cesca Therapeutics all in with ThermoGenesis, forms new subsidiary; shares up 25%Cesca Therapeutics all in with ThermoGenesis, forms new subsidiary; shares up 25%
seekingalpha.com - January 4 at 5:05 PM
U.S. STOCKS ON THE MOVE-Wells Fargo, CVS, Netflix, U.S.-listed Chinese shares - NasdaqU.S. STOCKS ON THE MOVE-Wells Fargo, CVS, Netflix, U.S.-listed Chinese shares - Nasdaq
www.nasdaq.com - January 4 at 10:19 AM
Cesca Therapeutics Acquires Remaining Ownership Stake in ThermoGenesis and Forms New ThermoGenesis Subsidiary, CARTXpress Bio, Inc., to Focus on its CAR-TXpress Cellular Processing PlatformCesca Therapeutics Acquires Remaining Ownership Stake in ThermoGenesis and Forms New ThermoGenesis Subsidiary, CARTXpress Bio, Inc., to Focus on its CAR-TXpress Cellular Processing Platform
finance.yahoo.com - January 4 at 10:19 AM
4 Healthcare Stocks You Should Get To Know Before 20194 Healthcare Stocks You Should Get To Know Before 2019
finance.yahoo.com - November 20 at 4:43 PM
Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP® II AutoXpress® Platform for Clinical Cord Blood BankingCesca Therapeutics Receives 510(k) Clearance to Market Its AXP® II AutoXpress® Platform for Clinical Cord Blood Banking
finance.yahoo.com - November 19 at 4:40 PM
Cesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q3 2018 Results - Earnings Call TranscriptCesca Therapeutics Inc. (KOOL) CEO Chris Xu on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 15 at 9:06 AM
Cesca Therapeutics (KOOL) Submits MAF with the FDA for X-LAB Automated Cell Processing DevicesCesca Therapeutics (KOOL) Submits MAF with the FDA for X-LAB Automated Cell Processing Devices
www.streetinsider.com - November 14 at 4:40 PM
Cesca Therapeutics Announces Third Quarter 2018 Financial Results And Provides Corporate UpdateCesca Therapeutics Announces Third Quarter 2018 Financial Results And Provides Corporate Update
finance.yahoo.com - November 14 at 4:40 PM
Cesca up 29% on advancement of X-LAB deviceCesca up 29% on advancement of X-LAB device
seekingalpha.com - November 13 at 4:39 PM
Cesca Therapeutics Submits Device Master File (MAF) with the FDA for the X-LAB® Automated Cell Processing DevicesCesca Therapeutics Submits Device Master File (MAF) with the FDA for the X-LAB® Automated Cell Processing Devices
finance.yahoo.com - November 13 at 8:54 AM
Cesca Therapeutics To Announce Financial Results For The Third Quarter Ended September 30, 2018 And Host Conference Call On November 14Cesca Therapeutics To Announce Financial Results For The Third Quarter Ended September 30, 2018 And Host Conference Call On November 14
finance.yahoo.com - November 7 at 9:20 AM
Will Cesca Therapeutics (KOOL) Report Negative Earnings Next Week? What You Should KnowWill Cesca Therapeutics (KOOL) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - November 6 at 4:40 PM
Cesca Therapeutics (KOOL) Dips More Than Broader Markets: What You Should KnowCesca Therapeutics (KOOL) Dips More Than Broader Markets: What You Should Know
finance.yahoo.com - November 3 at 9:30 AM
Cesca Therapeutics (KOOL) Stock Moves -0.73%: What You Should KnowCesca Therapeutics (KOOL) Stock Moves -0.73%: What You Should Know
finance.yahoo.com - October 19 at 9:25 AM
This page was last updated on 8/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel